| Literature DB >> 35324809 |
Federico Arippa1,2, Bruno Leban1, Marco Monticone2,3, Giovanni Cossu4, Carlo Casula5, Massimiliano Pau1.
Abstract
Unilaterality of motor symptoms is a distinctive feature of Parkinson's Disease (PD) and represents an important co-factor involved in motor deficits and limitations of functional abilities including postural instability and asymmetrical gait. In recent times, an increasing number of studies focused on the characterization of such alterations, which have been associated with increased metabolic cost and risk of falls and may severely compromise their quality of life. Although a large number of studies investigated the gait alterations in people with PD (pwPD), few focused on kinematic parameters and even less investigated interlimb asymmetry under a kinematic point of view. This retrospective study aimed to characterize such aspects in a cohort of 61 pwPD (aged 68.9 ± 9.3 years) and 47 unaffected individuals age- and sex-matched (66.0 ± 8.3 years), by means of computerized 3D gait analysis performed using an optical motion-capture system. The angular trends at hip, knee and ankle joints of pwPD during the gait cycle were extracted and compared with those of unaffected individuals on a point-by-point basis. Interlimb asymmetry was assessed using angle-angle diagrams (cyclograms); in particular, we analyzed area, orientation, trend symmetry and range offset. The results showed that pwPD are characterized by a modified gait pattern particularly at the terminal stance/early swing phase of the gait cycle. Significant alterations of interlimb coordination were detected at the ankle joint (cyclogram orientation and trend symmetry) and at the hip joint (range offset). Such findings might be useful in clinical routine to characterize asymmetry during gait and thus support physicians in the early diagnosis and in the evaluation of the disease progression.Entities:
Keywords: Parkinson’s disease; gait; kinematics; symmetry
Year: 2022 PMID: 35324809 PMCID: PMC8945156 DOI: 10.3390/bioengineering9030120
Source DB: PubMed Journal: Bioengineering (Basel) ISSN: 2306-5354
Figure 1Graphic representation of a cyclogram and its main features considered for the present study.
Demographic, anthropometric, and clinical characteristics of participants. Values are expressed as mean ± SD.
| Control Group (19 F, 28 M) | PD Group (24 F, 37 M) | |
|---|---|---|
| Age (years) | 66.0 ± 8.3 | 68.9 ± 9.3 |
| Body mass (kg) | 66.9 ± 11.1 | 67.1 ± 10.9 |
| Height (cm) | 164.7 ± 6.9 | 164.5 ± 7.8 |
| Disease Duration (years) | - | 7.7 ± 5.6 |
| UPDRS III score | - | 19.9 ± 9.3 |
Spatiotemporal parameters of gait. Stance, swing and double support phases are expressed as percentage of the gait cycle duration. Values are expressed as mean ± SD.
| Control Group | PD Group | |
|---|---|---|
| Speed (m/s) | 1.18 ± 0.22 | 1.06 ± 0.26 ** |
| Cadence (steps/min) | 112.32 ± 10.24 | 111.49 ± 12.99 |
| Step Length (m) | 0.63 ± 0.08 | 0.55 ± 0.11 ** |
| Step Width (m) | 0.20 ± 0.02 | 0.19 ± 0.04 |
| Stance Phase (% of the gait cycle) | 59.96 ± 1.65 | 60.77 ± 2.62 |
| Swing Phase (% of the gait cycle) | 40.06 ± 1.65 | 38.67 ± 2.47 ** |
| Double Support Phase (% of the gait cycle) | 20.07 ± 3.29 | 22.60 ± 4.73 ** |
The symbol ** denotes a significant difference with respect to the Control Group (in all cases p < 0.01).
SI parameters of gait. Stance, swing and double support phases are expressed as percentage of the gait cycle duration. Values are expressed as mean ± SD.
| Symmetry Index | Control Group | PD Group |
|---|---|---|
| Step Length | 2.90 ± 1.92 | 4.90 ± 3.52 ** |
| Stance Phase Duration | 1.66 ± 1.20 | 2.39 ± 2.94 |
| Swing Phase Duration | 2.45 ± 1.79 | 3.62 ± 4.04 |
| Double Support Phase Duration | 7.90 ± 6.29 | 14.22 ± 17.03 * |
The symbols * and ** denote a significant difference with respect to the Control Group (* p < 0.05, ** p < 0.01).
GPS and GVS indexes (in degrees). Values are expressed as mean ± SD.
| Control Group | PD Group | |
|---|---|---|
| GPS | 6.60 ± 1.35 | 7.37 ± 1.31 ** |
| Pelvic Obliquity GVS | 2.23 ± 0.88 | 2.60 ± 0.95 * |
| Pelvic Tilt GVS | 5.45 ± 3.14 | 6.04 ± 3.55 |
| Pelvic Rotation GVS | 3.35 ± 1.02 | 4.18 ± 1.34 ** |
| Hip Abduction–Adduction GVS | 3.69 ± 1.29 | 3.94 ± 1.29 |
| Hip Flexion–Extension GVS | 7.96 ± 3.35 | 8.54 ± 4.14 |
| Hip Rotation GVS | 7.83 ± 3.23 | 8.86 ± 3.14 |
| Knee Flexion–Extension GVS | 7.61 ± 2.51 | 8.98 ± 2.69 ** |
| Ankle Dorsi–plantarflexion GVS | 5.84 ± 1.99 | 6.34 ± 2.21 |
| Foot Progression GVS | 7.94 ± 2.60 | 8.47 ± 3.64 |
The symbols * and ** denote a significant difference with respect to the Control Group (* p < 0.05, ** p < 0.01).
Dynamic range of motion during gait (in degrees). Values are expressed as mean ± SD.
| Joint | Control Group | PD Group |
|---|---|---|
| Hip ROM | 46.52 ± 6.11 | 42.02 ± 5.89 ** |
| Knee ROM | 58.80 ± 4.67 | 55.69 ± 5.53 ** |
| Ankle ROM | 26.47 ± 4.94 | 24.93 ± 4.98 |
The symbol ** denotes a significant difference with respect to the control group (p < 0.01).
Figure 2Gait kinematics in the sagittal plane. From top to bottom: hip flexion–extension, knee flexion–extension and ankle dorsi–plantar-flexion angles during gait cycle. Gray-shaded areas denote the periods of the gait cycle in which a significant difference between groups existed (p < 0.05).
Comparison between symmetry indexes of PD and CG subjects. Values are expressed as mean ± SD.
| Cyclogram Parameter | Control Group | PD Group | |
|---|---|---|---|
| Area | 116.57 ± 88.11 | 87.95 ± 72.18 | |
| Hip | Orientation | 2.26 ± 2.36 | 1.92 ± 1.76 |
| Trend Symmetry | 0.24 ± 0.21 | 0.29 ± 0.26 | |
| Range Offset | 2.27 ± 2.02 | 3.22 ± 2.08 * | |
| Area | 268.76 ± 213.97 | 213.53 ± 156.65 | |
| Knee | Orientation | 1.47 ± 1.40 | 1.62 ± 1.35 |
| Trend Symmetry | 0.49 ± 0.42 | 0.48 ± 0.32 | |
| Range Offset | 4.52 ± 3.97 | 5.50 ± 3.22 | |
| Area | 62.52 ± 51.59 | 84.58 ± 63.71 | |
| Ankle | Orientation | 1.99 ± 1.44 | 3.92 ± 2.80 * |
| Trend Symmetry | 1.54 ± 1.21 | 2.27 ± 1.48 * | |
| Range Offset | 2.83 ± 2.05 | 3.57 ± 2.63 |
The symbol * denotes a significant difference with respect to the control group.
Figure 3Comparison between cyclograms of an individual affected by PD and an unaffected individual. The diagram refers to the ankle joint.